Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment. Organized as national non-profit member organization, the 95+ members represent the entire value chain including academic research institutes, university hospitals, start-ups, biotech and international Pharma companies. The cluster is advancing a growing pipeline of preclinical and clinical stage assets with strength in cancer immunotherapy and precision medicine.
